Differential antiviral activity of derivatized dextrans
- 1 September 1995
- journal article
- research article
- Published by Elsevier in Biochemical Pharmacology
- Vol. 50 (6) , 743-751
- https://doi.org/10.1016/0006-2952(95)00193-4
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- In vitro and in vivo inhibition of ortho- and paramyxovirus infections by a new class of sulfonic acid polymers interacting with virus-cell binding and/or fusionAntimicrobial Agents and Chemotherapy, 1994
- Antiproliferative capacity of synthetic dextrans on smooth muscle cell growth: the model of derivatized dextrans as heparin-like polymersJournal of Biomaterials Science, Polymer Edition, 1993
- In vitro stimulation of human endothelial cells by derivatized dextransIn Vitro Cellular & Developmental Biology – Animal, 1993
- Sulfated polymers inhibit the interaction of human cytomegalovirus with cell surface heparan sulfateVirology, 1992
- Derivatized dextran inhibition of smooth muscle cell proliferationJournal of Biomaterials Science, Polymer Edition, 1992
- Derivatized dextrans mimic heparin as stabilizers, potentiators, and protectors of acidic or basic FGFJournal of Cellular Physiology, 1992
- Differential inhibitory effects of sulfated polysaccharides and polymers on the replication of various myxoviruses and retroviruses, depending on the composition of the target amino acid sequences of the viral envelope glycoproteinsAntimicrobial Agents and Chemotherapy, 1991
- Molecular weight dependency of the acquired anticomplementary and anticoagulant activities of specifically substituted dextransBiomaterials, 1987
- Anticomplementary activity of dextran derivativesBiomaterials, 1985
- Anticoagulant activity of dextran derivatives. Part I: Synthesis and characterizationBiomaterials, 1984